{"title": "Welcome! - Treatment Action Group", "author": null, "url": "https://www.treatmentactiongroup.org/", "hostname": "treatmentactiongroup.org", "description": null, "sitename": "Treatment Action Group", "date": "2019-05-08", "cleaned_text": "September 5, 2023 [ HCV Elimination Among People Living with and at Risk of HIV: Challenges and Opportunities ](https://www.treatmentactiongroup.org/webinar/hcv-elimination-among-people-living-with-and-at-risk-of-hiv-challenges-and-opportunities/) Webinar / Presentation Following the White House's recent proposal for a National Hepatitis C Elimination Plan as part of its Fiscal Year 2024 budget request to Congress, and the fact that key populations for HIV are also at high risk of HCV, Treatment Action Group is organizing a webinar that will highlight best... August 16, 2023 [ HIV Community Engagement Manager ](https://www.treatmentactiongroup.org/about-us/work-with-us/hiv-community-engagement-manager/) Treatment Action Group (TAG) seeks a dynamic, motivated, and skilled individual to become its HIV community engagement manager, supporting the organization as it continues to grow. This position will report to TAG's HIV project director, and is a full-time, salaried role. August 16, 2023 [ Information Note: New Fair Share Funding Targets for TB Research 0.1% -> 0.15% ](https://www.treatmentactiongroup.org/publication/information-note-new-fair-share-funding-targets-for-tb-research-0-1-0-15/) Publication In 2017 Treatment Action Group and partners introduced the \"fair share\" funding targets for TB research. August 16, 2023 [ Research Toward a Cure Trials ](https://www.treatmentactiongroup.org/cure/trials/) A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s). August 10, 2023 [ Letter to Dr. Jeanne Marazzo, New Director NIAID ](https://www.treatmentactiongroup.org/letter/letter-to-dr-jeanne-marazzo-new-director-niaid/) Letter / Comment We're excited to welcome Dr. Jeanne Marazzo as the first woman and openly LGBTQ+ Director of the National Institute of Allergy and Infectious Diseases (NIAID). August 8, 2023 [ TAG Mourns the Loss of Dr. Stephaun Elite Wallace ](https://www.treatmentactiongroup.org/statement/tag-mourns-the-loss-of-dr-stephaun-elite-wallace/) Statement / Press TAG extends our deepest condolences to the family, friends and loved ones of Dr. Stephaun Elite Wallace, PhD, MS. Dr. Wallace was a treasure to all who knew and worked with him, and his legacy of mentorship and community engagement in the HIV research landscape will be felt for generations. August 2, 2023 [ TAG Welcomes Addition of Ravidasvir to WHO Essential Medicines List for Treatment of Hepatitis C Virus ](https://www.treatmentactiongroup.org/statement/tag-welcomes-addition-of-ravidasvir-to-who-essential-medicines-list-for-treatment-of-hepatitis-c-virus/) Statement / Press Treatment Action Group welcomes the inclusion of Ravidasvir on the World Health Organization (WHO) Essential Medicines List (EML) as a direct-acting antiviral (DAA) for the treatment of chronic hepatitis C virus (HCV) infection in adults. August 1, 2023 [ Open letter: Requesting Clarification on the Recent Deal on Generic Bedaquiline Supply ](https://www.treatmentactiongroup.org/letter/open-letter-requesting-clarification-on-the-recent-deal-on-generic-bedaquiline-supply/) Letter / Comment TAG, Partners In Health, and MSF Access Campaign sent an open letter to Johnson & Johnson requesting detailed responses to questions and concerns regarding the deal with the Global Drug Facility to supply generic bedaquiline to low- and middle-income countries that excludes South Africa, 10 EECA countries, and China. July 20, 2023 [ 2023 Pipeline Report ](https://www.treatmentactiongroup.org/resources/pipeline-report/2023-pipeline-report/) Pipeline Report Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB). July 13, 2023 [ TAG Encouraged by J&J Deal to Reduce Bedaquiline Prices, but Company's Action Falls Short of Community Demands ](https://www.treatmentactiongroup.org/statement/tag-encouraged-by-jj-deal-to-reduce-bedaquiline-prices-but-companys-action-falls-short-of-community-demands/) Statement / Press After over a year of sustained advocacy from the TB community demanding that Johnson & Johnson publicly commit to non-enforcement or withdrawal of secondary patents on bedaquiline filed in 66 low- and middle-income countries (LMICs)... July 12, 2023 [ Broadly Neutralizing Antibodies (bNAbs) and HIV Cure-Related Research ](https://www.treatmentactiongroup.org/publication/broadly-neutralizing-antibodies-bnabs-and-hiv-cure-related-research/) Publication HIV has evolved multiple mechanisms to evade inhibition by antibodies, which are Y-shaped immune system proteins that normally play a key role in fending off or controlling infections. July 11, 2023 [ Open Letter: Urgent Action Necessary for Equitable Access to Bedaquiline in All Countries with High Burdens of TB, MDR-TB, and TB/HIV ](https://www.treatmentactiongroup.org/letter/open-letter-urgent-action-necessary-for-equitable-access-to-bedaquiline-in-all-countries-with-high-burdens-of-tb-mdr-tb-and-tb-hiv/) Letter / Comment TAG and 82 other organizations and 106 individuals representing TB-affected communities and civil society sent an open letter to Johnson & Johnson calling on the company... July 11, 2023 [ An Activist's Protocol Review Toolkit ](https://www.treatmentactiongroup.org/publication/an-activists-protocol-review-toolkit/) Publication An Activist's Protocol Review Toolkit is designed to facilitate community participation in the development and review of clinical trials protocols. June 20, 2023 [ 2022 Annual Report ](https://www.treatmentactiongroup.org/publication/2022-annual-report/) Publication As we close another year of unprecedented challenges and achievements, I'm honored to share with you Treatment Action Group's (TAG) 2022 Annual Report. June 16, 2023 [ The ABC for a TB Activist: 1/4/6\u00d724 Campaign and Supportive Diagnostics ](https://www.treatmentactiongroup.org/webinar/the-abc-for-a-tb-activist-1-4-6x24-campaign-and-supportive-diagnostics/) Webinar / Presentation On 15 June, 2023, TB Europe Coalition (TBEC) organized a webinar featuring a presentation by Treatment Action Group's TB Project Officer, David Branigan, on the practical actions advocates can take to promote the adoption and scale up of shorter, safer 1/4/6 regimens for TB prevention and the treatment of drug-sensitive... June 15, 2023 [ SMART4TB CONSORTIUM ANNOUNCES COMMUNITY PARTNERS ](https://www.treatmentactiongroup.org/statement/smart4tb-consortium-announces-community-partners/) Statement / Press Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB) is a five-year cooperative agreement made possible by the United States Agency for International Development (USAID), with the assistance of the American people, that aims to transform tuberculosis (TB) prevention and care. June 7, 2023 [ Director of Development ](https://www.treatmentactiongroup.org/about-us/work-with-us/director-of-development/) Treatment Action Group (TAG) seeks a dynamic, motivated, and skilled individual to become its Director of Development supporting the organization as it continues to grow. June 6, 2023 [ Treatment Action Group Welcomes Moe Ari Brown as Newest Board Member ](https://www.treatmentactiongroup.org/statement/treatment-action-group-welcomes-moe-ari-brown-as-newest-board-member/) Statement / Press Treatment Action Group (TAG) is pleased to announce the election of Moe Ari Brown to our Board of Directors. May 19, 2023 [ TAG's Submission to OHCHR for GA78 Report ](https://www.treatmentactiongroup.org/letter/tags-submission-to-onhcr-for-ga78-report/) Letter / Comment TAG recently submitted this input for the Office of the High Commissioner on Human Rights (ONHCR) Independent Expert on Foreign Debt and Human Rights thematic report for the UN General Assembly 78 later this year. May 10, 2023 [ Why Hepatitis C Virus Care Remains Inaccessible ](https://www.treatmentactiongroup.org/publication/why-hepatitis-c-virus-care-remains-inaccessible/) Publication This policy brief explores barriers such as the high-burden among marginalized communities, the complicated diagnostic process, and the difficulties of finding the missing millions of people with HCV in most high-burden countries. May 9, 2023 [ Research in Action Awards 2023 ](https://www.treatmentactiongroup.org/support-us/riaa-2023/) Save the date for Monday, October 19! TAG's 2023 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world. May 8, 2023 [ TAG Remarks Delivered at Multistakeholder Hearings, May, 2023 ](https://www.treatmentactiongroup.org/publication/tag-remarks-delivered-at-multistakeholder-hearings-may-2023/) Publication TAG prepared these remarks to deliver at multistakeholder hearings on health held on May 8 and 9, 2023, at the United Nations Headquarters in New York City. April 19, 2023 [ Nitrosamines and TB Medicines Information Note and Patient FAQs ](https://www.treatmentactiongroup.org/publication/nitrosamines-and-tb-medicines-information-note-and-patient-faqs/) Publication In 2020, health authorities and drug manufacturers identified a type of chemical impurity called nitrosamines in rifampicin and rifapentine, two essential medicines used in the treatment and prevention of TB. TAG and IMPAACT4TB project partners have developed several materials to help people affected by TB, advocates, policymakers, and implementers understand... March 30, 2023 [ 35 Years of Art to End AIDS Exhibition Catalog ](https://www.treatmentactiongroup.org/publication/35-years-of-art-to-end-aids-exhibition-catalog/) Publication TAG is presenting the exhibition \"35 Years of Art to End AIDS\" at Melissa Morgan Fine Art in Palm Desert, California, from March 17 through April 7, 2023. This exhibit features selected works form our Limited Art Editions collection. March 28, 2023 [ The 1/4/6\u00d724 Campaign Coalition Welcomes India's Rejection of Johnson & Johnson's Patent Evergreening Tactic ](https://www.treatmentactiongroup.org/statement/the-1-4-6x24-campaign-coalition-welcomes-indias-rejection-of-johnson-johnsons-patent-evergreening-tactic/) Statement / Press The Indian Patent Office has taken a laudable step that will pave the way for generic manufacturing of a key tuberculosis (TB) drug. "}